Literature DB >> 6156971

Detection and quantitation of hepatitis B surface antigen immune complexes (HBsAg-ICs) by an antigen-specific method. II. Circulating immune complexes (CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.

N Anh-Tuan, E Novák.   

Abstract

Using the PEG-trypsinisation assay, HBsAg-CICs were detected in 70% of patients with acute hepatitis B, in 5% of the asymptomatic HBsAg carriers and, in addition, in each of the 2 cases of chronic hepatitis B virus infection. In serial examinations, the complexed HBsAg levels in 77% of patients with acute hepatitis B decreased progressively in parallel with the free HBsAg levels, and persisted in the remaining 23%. In 19% of patients positive for HBsAg-CICs, the complexed HBsAg levels were higher than those of free HBsAg. No correlation was observed between results of PEG-trypsinisation and an anticomplementary assay. Artificial HBsAg-ICs in antigen excess were found to be poorly anticomplementary. C3 concentrations were normal or elevated in the majority (88%) of sera positive for HBsAg-CICs. These findings suggest that HBsAg-CICs in antigen excess are unlikely to be complement-activating. The method is useful for clinical investigation and for routine examination for HBsAg-CICs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156971     DOI: 10.1016/0022-1759(80)90257-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

Review 1.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

2.  Drastic reduction in the production of subviral particles does not impair hepatitis B virus virion secretion.

Authors:  Tamako Garcia; Jisu Li; Camille Sureau; Kiyoaki Ito; Yanli Qin; Jack Wands; Shuping Tong
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

3.  Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis.

Authors:  Katarzyna A Gustaw; Matthew R Garrett; Hyoung-Gon Lee; Rudy J Castellani; Michael G Zagorski; Annamalai Prakasam; Sandra L Siedlak; Xiongwei Zhu; George Perry; Robert B Petersen; Robert P Friedland; Mark A Smith
Journal:  J Neurochem       Date:  2008-05-12       Impact factor: 5.372

4.  Antibody responses during hepatitis B viral infection.

Authors:  Stanca M Ciupe; Ruy M Ribeiro; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2014-07-31       Impact factor: 4.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.